Clinical Trials at University of Kentucky
As of September 2026, 106 paid clinical trials are recruiting at University of Kentucky, located at University of Kentucky Research Foundation, Kinkead Hall, 201 Kinkead Hall, Lexington, KY 40508, phone (859) 257-8311 in Lexington, Kentucky. Active studies at this site cover conditions such as Heart Failure, Acute Myeloid Leukemia and Breast Cancer. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Filter results
Newly added in Lexington
Posted to ClinicalTrials.gov within the last 60 days — these studies are just starting to recruit.
Project SHIELD 2.0: Police Education to Support Public Health in Kentucky
108 clinical trials at University of Kentucky
·Clear filters·Phase 2 Study to Assess the Safety and Efficacy of ANG003
A Clinical Study of Calderasib (MK-1084) With Targeted Therapy and Chemotherapy in People With Colorectal Cancer (MK-1084-012/KANDLELIT-012)
A Study to Evaluate Zilovertamab Vedotin (MK-2140) Combination With Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) in Participants With Previously Untreated DLBCL (MK-2140-010)
Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML
A Phase 2 Study and Open-Label Extension of NEU-411 in Companion Diagnostic-Positive Participants With Early Parkinson's Disease
SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)
Investigation of the BrioVAD System for the Treatment of Left Ventricular Heart Failure
A Study to Evaluate Avacopan in Participants With ANCA-associated Vasculitis
A Study of Patients With Lower Extremity Acute Limb Ischemia to Remove Thrombus With the Indigo™ Aspiration System (STRIDE II)
Multi-site Study of the Clinical Impact of an AI-assisted Approach to Referring Patients With Interstitial Lung Disease for Diagnostic Evaluation of Pulmonary Hypertension
Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)
Endurant Stent Graft System vs Excluder Endoprothesis: ADVANCE Trial
Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart Failure
A Study of Telitacicept for the Treatment of Generalized Myasthenia Gravis (UPSTREAM MG)
US National OCS Heart Perfusion (OHP) Registry
An Evaluation of the AeriSeal System for CONVERTing Collateral Ventilation Status in Patients With Severe Emphysema
Clinical Trial Evaluating the Safety and Efficacy of Nucleus Pulposus Allograft in Participants With Degenerative Disc Disease
A Study to Compare How Well Odronextamab Combined With Chemotherapy Works and How Safe it is Against Rituximab Combined With Chemotherapy, in Adult Patients With Previously Untreated Diffuse Large B-cell Lymphoma
AtraUmatic Laparoscopic HerNia Repair Clinical Investigation to Evaluate the Safety and Performance of The ECLIPSIUM System for Mesh Fixation IDE
WRAP North America
Lead-212 PSV359 Therapy for Patients With Solid Tumors
MC1R-targeted Alpha-particle Monotherapy and Combination Therapy Trial With Nivolumab in Adults With Advanced Melanoma
A Study With Eptinezumab in Children and Adolescents (6 to 17 Years) With Chronic or Episodic Migraine
Targeted Alpha-Particle Therapy for Advanced Somatostatin Receptor Type 2 (SSTR2) Positive Tumors
CERAMENT™| Bone Void Filler Device Registry
A Clinical Trial of MK-1045 and Rituximab in People With Follicular Lymphoma (MK-1045-007)
A Study to Evaluate DJI136, a DLL3-targeted CAR-T Therapy
A Study of Pembrolizumab With or Without Chemotherapy in Combination With Additional Treatments for Advanced Non-Small Cell Lung Cancer (NSCLC) (MK-3475-01G/KEYMAKER U01)
PT150 Drug for Use in Alcohol Use Disorder
GORE® ENFORM Biomaterial Product Study
Evaluating Clinical Hiatal Hernia Outcomes Using OviTex®
Efficacy and Safety of Masitinib Versus Placebo in the Treatment of ALS Patients
Repeated CBD Administration and Cannabis Outcomes
Metastatic Ewing's Trial Testing Schedule Enhancement to Improve Outcomes
Parkinson's Foundation PD GENEration Genetic Registry
Neuromodulation to Enhance Motor Function in HSP
Abatacept in Immune Checkpoint Inhibitor Myocarditis
Digoxin Medulloblastoma Study
Mitigating the Disinhibiting Effects of Alcohol With Transcranial Magnetic Stimulation
Exercise and Emotional Learning in Posttraumatic Stress Disorder
Common conditions studied in Lexington
- Heart Failure (10 active studies)
- Acute Myeloid Leukemia (8 active studies)
- Breast Cancer (8 active studies)
- Obesity (8 active studies)
- Ovarian Cancer (8 active studies)
- Malignant Solid Neoplasm (7 active studies)
Leading research sponsors in Lexington
- National Cancer Institute (NCI)
- SWOG Cancer Research Network
- AstraZeneca
- Children's Oncology Group
- NRG Oncology
Frequently asked questions
How many paid clinical trials are currently recruiting in Lexington?
There are approximately 462 recruiting clinical trials in Lexington, Kentucky listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Lexington pay participants?
Most recruiting trials in Lexington compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Lexington?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Lexington?
The most common conditions under active study in Lexington include Heart Failure (10), Acute Myeloid Leukemia (8), Breast Cancer (8), Obesity (8), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Lexington?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Lexington on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Lexington?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Lexington?
Recruiting research sites in Lexington include University of Kentucky, University of Kentucky/Markey Cancer Center, Baptist Health Lexington, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Lexington right now?
The largest active categories in Lexington are Cancer & tumors (181), Cardiovascular (32), Neurology & pain (30). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.
What is the address of University of Kentucky?
University of Kentucky is located at University of Kentucky Research Foundation, Kinkead Hall, 201 Kinkead Hall, Lexington, KY 40508. Use the Google Maps link in the intro above to get directions.
How do I contact University of Kentucky?
You can reach University of Kentucky by phone at (859) 257-8311. For questions about a specific trial, use the study coordinator contact listed on the individual study record — click any trial title above to open it.